Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase

Nosocomial dissemination of extended-spectrum β-lactamase VEB-1a-producing Providencia stuartii isolates in a Tunisian hospital

(2011) H. Lahlaoui et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations

(2011) Carolina Pasa Vianna et al.   JOURNAL OF MOLECULAR MODELING

Sulbactam-containing β-lactamase inhibitor combinations

(2008) M. Akova   CLINICAL MICROBIOLOGY AND INFECTION

Increase in  -lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type  -lactamases

(2008) L. M. Aragon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii

(2008) M. D. Adams et al.   JOURNAL OF BACTERIOLOGY

Molecule-pharmacophore superpositioning and pattern matching in computational drug design

(2007) G WOLBER   DRUG DISCOVERY TODAY